Back

Relationship between the new SCORE2-Diabetes and coronary atherosclerotic burden - a coronary calcium score correlation study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Scores (1) Scores ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Joana Certo Pereira

Hospital de Santa Cruz, Carnaxide (Portugal)

6 More presentations in this session

Presentation thumbnail
Should preventive treatment decisions be informed by short or long-term cardiovascular risk? Short and long-term risk profiles of over 2 million New Zealanders aged over 25 years
Miss J. Liang (Auckland, NZ)
Abstract Slides Video
Presentation thumbnail
The relationship between PREVENT equations and the prevalence of cardiac dysfunction, and the coronary atherosclerosis index
Doctor M. Suzuki (Aichi, JP)
Abstract Slides Video
Presentation thumbnail
Relationship between acute effects on cardiovascular risk in an immersive lifestyle medicine program
Mr J. Batista De Souza (Foz Do Iguacu, BR)
Abstract Slides Video
Presentation thumbnail
SCORE2 tables do not assign the same risk category as the underlying model in almost 20% of Polish primary care patients
Associate Professor T. Osadnik (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
ESC Guidelines for cardiovascular prevention: do they apply to heart transplanted patients?
Doctor N. Gallingani (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Scores (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Evaluation of coronary plaque burden in type 2 diabetes: insights from a propensity-matched CCTA study
thumbnail
Congress Presentation
Prognostic value of quantitative anatomical and functional measures of coronary artery disease in diabetic and non-diabetic patients
thumbnail
Congress Presentation
Impact of impaired glucose metabolism on coronary atherosclerosis in patients with very low LDL cholesterol: a potential framework to understand residual risk in chronic coronary syndromes.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources